Zweig Advisers’s Pfizer PFE Stock Holding History

Zweig Advisers’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-209,746	Closed	-$7.34M	–	53
2016 Q2	$7.34M	Buy	209,746 +114,886	+121%	+$3.67M	1.25%	36
2016 Q1	$2.67M	Hold	94,860	–	–	0.45%	66
2015 Q4	$2.9M	Sell	94,860 -7,378	-7%	-$232K	0.48%	65
2015 Q3	$3.05M	Hold	102,238	–	–	0.53%	60
2015 Q2	$3.25M	Hold	102,238	–	–	0.49%	59
2015 Q1	$3.38M	Sell	102,238 -22,134	-18%	-$704K	0.48%	55
2014 Q4	$3.68M	Hold	124,372	–	–	0.5%	59
2014 Q3	$3.49M	Sell	124,372 -60,078	-33%	-$1.69M	0.5%	61
2014 Q2	$5.19M	Hold	184,450	–	–	0.73%	68
2014 Q1	$5.62M	Buy	+184,450	New	+$5.5M	0.8%	66

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Zweig Advisers's PFE Position: Q3 2016 in Review

Zweig Advisers sold out of Pfizer (PFE) in Q3 2016, closing a stake of 209,746 shares — an estimated $7.34M sold.

Zweig Advisers first reported a position in PFE in Q1 2014 and held it in 10 quarters. The position peaked at $7.34M in Q2 2016. 1,962 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

Zweig Advisers reported no remaining Pfizer position as of Q3 2016 after selling out during the quarter.
Zweig Advisers sold 209,746 Pfizer shares in Q3 2016, an estimated $7.34M.
Zweig Advisers first reported a position in Pfizer in Q1 2014 and held it in 10 quarters.
Zweig Advisers's Pfizer position peaked at $7.34M in Q2 2016.
1,962 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on Zweig Advisers's 13F filing for Q3 2016.